Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 21/Signature 2
From BugSigDB
Needs review
Source: Additional file 11: Figure S11
Description: Differentially abundant between the Naive group and HZ (H-Isoniazid, Z-Pyrazinamide) treatment group.
Abundance in Group 1: decreased abundance in HZ (H-Isoniazid, Z-Pyrazinamide)
| NCBI | Quality Control | Links |
|---|---|---|
| Eubacteriales Family XIII. Incertae Sedis | ||
| Guggenheimella | ||
| Arthrobacter | ||
| Ruminococcus | ||
| Clostridium | ||
| Sporobacter | ||
| Coprobacter | ||
| Akkermansia |
Revision editor(s): KateRasheed
